Related Experiment Video
Updated: Jul 26, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Ascending aorta dilatation is associated to hard cardiovascular events, follow-up from multicentric ARGO-Perspective
Lorenzo Airale1, Francesco Borrelli1, Alessio Arrivi2
1Department of Medical Sciences, Hypertension Center-University of Torino-AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Insights
Aortic root dilatation is linked to a higher risk of major adverse cardiovascular events in hypertensive patients. This finding highlights aortic dilatation as a significant predictor of cardiovascular outcomes, even after accounting for other risk factors.
Area of Science:
- Cardiology
- Hypertension Research
- Vascular Medicine
Background:
- Aortic root dilatation is a potential hypertension-mediated organ damage (HMOD).
- Previous studies on aortic root dilatation as HMOD are heterogeneous, lacking clarity on its role.
- Essential hypertension poses significant cardiovascular risks, necessitating identification of all HMODs.
Purpose of the Study:
- To investigate the association between aortic root dilatation (AAD) and major adverse cardiovascular events (MACE).
- To determine if AAD is an independent predictor of MACE in patients with essential hypertension.
- To clarify the role of AAD as a potential HMOD.
Main Methods:
- A cohort of 445 hypertensive patients was recruited from six Italian hospitals (ARGO-SIIA study).
- Patients were followed for a median of 60 months, with data collected via telephone and hospital records.
- Aortic dilatation was defined using sex-specific thresholds (41 mm for males, 36 mm for females).
Main Results:
- AAD was significantly associated with an increased occurrence of MACE (HR=4.07, p<0.001).
- This association remained significant after adjusting for age, sex, and body surface area (HR=2.91, p=0.020).
- AAD was an independent predictor of MACE, even after correction for established HMODs like left atrial enlargement and left ventricular hypertrophy (HR=2.43, p=0.045).
Conclusions:
- Ascending aorta dilatation is associated with a substantially increased risk of MACE in hypertensive individuals.
- AAD should be considered a significant predictor of cardiovascular events in essential hypertension.
- Identifying and managing aortic root dilatation may be crucial for preventing cardiovascular complications in hypertensive patients.
Abstract:
Aortic root dilatation has been proposed as hypertension-mediated organ damage (HMOD). Nevertheless, the role of the aortic root dilatation as a possible additional HMOD is still unclear since studies conducted so far are quite heterogeneous regarding the type of population analyzed, the aortic tract considered, and the type of outcomes accounted for. The aim of the present study is to assess whether the presence of aortic dilatation is associated with strong cardiovascular (CV) events (MACE: heart failure, CV death, stroke, acute coronary syndrome, myocardial revascularization) in a population of patients affected by essential hypertension. Four hundred forty-five hypertensive patients from six Italian hospitals were recruited as part of ARGO-SIIA study1. For all centers, follow-up was obtained by re-contacting all patients by telephone and through the hospital's computer system. Aortic dilatation (AAD) was defined through absolute sex-specific thresholds as in previous studies (41 mm for males, 36 mm for females). Median follow-up was 60 months. AAD was found to be associated with the occurrence of MACE (HR = 4.07 [1.81-9.17], p < 0.001). This result was confirmed after correction for main demographic characteristics such as age, sex and BSA (HR = 2.91 [1.18-7.17], p = 0.020). At penalized Cox regression, age, left atrial dilatation, left ventricular hypertrophy and AAD were identified as best predictor of MACEs and AAD resulted a significant predictor of MACEs even after correction for these confounders (HR = 2.43 [1.02-5.78], p = 0.045). The presence of AAD was found to be associated with an increased risk of MACE independently of for major confounders, including established HMODs. AAD ascending aorta dilatation, LAe left atrial enlargement, LVH left ventricular hypertrophy, MACEs major adverse cardiovascular events, SIIA Società Italiana dell'Ipertensione Arteriosa (Italian Society for Arterial Hypertension).
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Aneurysm I: Introduction
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care

